Cambridge-based biotechnology company CN Bio has enhanced its industry-leading drug-induced liver injury (DILI) assay with new animal microphysiological system models, enabling comparative toxicity studies across human, rat, and dog liver models to improve preclinical drug safety predictions.

Spring Bio Solution has unveiled NCE Grid, described as the world’s first free NCE-1 intelligence platform designed to decode and centralise Paragraph IV filing opportunities for generic pharmaceutical companies. The Somerset, New Jersey-based company launched the platform to address what it identifies as significant inefficiencies in current drug development intelligence gathering.

Belgian biotech company Perseus Biomics has partnered with hardware developer Comate to launch MetaMAP, a compact automated system capable of delivering comprehensive gut microbiome analysis in 6.5 hours. The device addresses long-standing challenges in microbiome research by combining high-resolution bacterial identification with unprecedented speed.

Thermo Fisher Scientific has unveiled the Applied Biosystems™ MagMAX™ Pro HT NoSpin Plasmid MiniPrep Kit, a breakthrough automation solution designed to eliminate bottlenecks in small-scale plasmid DNA isolation. The system delivers high-quality results in under 35 minutes, addressing critical efficiency demands across therapeutic research applications.

Roche has introduced the Elecsys PRO-C3 test, a breakthrough diagnostic solution that delivers liver fibrosis severity assessment results in just 18 minutes, addressing a critical gap in managing metabolic dysfunction-associated steatotic liver disease (MASLD) that affects approximately 30% of the global population.